Exchange: NASDAQ·Updated 11:17 AM EDT

FRNM Freenome, Inc.

$16.77
$0.17
(1.02%)
Today
Mkt Cap$1.78B
Vol158,711.00

About FRNM

Freenome, Inc. operates as an early detection company, which engages in the development of blood-based screening tests to detect cancer. Its proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The company was founded by Riley Ennis in 2014 and is headquartered in Brisbane, CA.
49

Neutral Sentiment

How do you feel about FRNM?

Cardfellow007
$FRNM Currently in $PSNL and contemplating wether to wait for $TEM takeover or move over into $FRNM. Biggest decision is tax implications
2
Laynester
$FRNM WALL STREET is all over [FRNM]. Main street can't make volume candles like these. Only Wall Street can. Stand by for News! (gains). 100%--->🦬
1
Cap_00
$FRNM I sold on that dip at $11 awhile back because I thought it was going to dip below $9. just horrible.
stockpicker63
🚀 STOCKS TO WATCH TODAY! 📈 🔥 $FRNM — Freenome is a fresh biotech listing focused on blood-based early cancer detection. With the stock near its recent highs, momentum traders should watch for continued strength and volume. ⚡ $BLSH — Bullish is attracting attention as crypto-market sentiment strengthens. Its recent Q2 results also beat expectations, making this one an interesting momentum play. 🚀 $SHOP — Shopify remains a major growth name. Q2 revenue jumped 34%, while the company delivered strong growth across GMV, gross profit and free cash flow. Today, SHOP is trading higher as tech sentiment improves. 👀 Keep $FRNM, $BLSH and $SHOP on your radar today — watch volume, breakouts and confirmation before chasing the move.

Advertisement|Remove ads.